
Deciphera Pharmaceuticals, a member of the ONO Group, develops and commercializes innovative oncology therapeutics. Leveraging a proprietary switch-control kinase inhibitor platform, the company focuses on discovering novel treatments that target dysregulated kinase pathways in cancer. Its deep expertise in kinase biology enables a broad portfolio of medicines designed to improve patient outcomes. Deciphera’s distinctive approach combines cutting-edge science with a commitment to delivering high-impact therapies to patients worldwide.
We are seeking a Medical Director for global pharmacovigilance. The successful candidate will lead and provide input on ongoing safety surveillance, benefit risk assessment, and risk management activities. The position will report to the Senior Medical Director of Pharmacovigilance and will be located in the Waltham office.
Deciphera Pharmaceuticals, a member of the ONO Group, develops and commercializes innovative oncology therapeutics. Leveraging a proprietary switch-control kinase inhibitor platform, the company focuses on discovering novel treatments that target dysregulated kinase pathways in cancer. Its deep expertise in kinase biology enables a broad portfolio of medicines designed to improve patient outcomes. Deciphera’s distinctive approach combines cutting-edge science with a commitment to delivering high-impact therapies to patients worldwide.